Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Alterity Therapeutics Ltd. ( (AU:ATH) ).
Alterity Therapeutics Limited has released a report detailing the top 20 holders of its listed options, which are set to expire on February 26, 2027, with a price of $0.028. The report highlights that UBS Nominees Pty Ltd holds the largest percentage of these options at 29.25%, followed by Citicorp Nominees Pty Limited with 18.11%. This information provides insights into the distribution of holdings among major investors, which could have implications for the company’s market strategy and investor relations.
More about Alterity Therapeutics Ltd.
Average Trading Volume: 1,000
Technical Sentiment Signal: Buy
Current Market Cap: $40.82M
See more insights into ATH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue